| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 12/27/2006 | CN1883597A Quickly acting medicine for treating cold and cough |
| 12/27/2006 | CN1883595A Chinese medicine for treating acute and chronic pharyngitis and application thereof |
| 12/27/2006 | CN1883566A Anti-inflammation medicine and method for preparing same |
| 12/27/2006 | CN1883564A Chinese medicinal capsule for treating inflammation and preparation process |
| 12/27/2006 | CN1883560A A compound Chinese medicinal preparation containing Chinese globeflower and method for preparing same |
| 12/27/2006 | CN1883543A A cough-stopping asthma-relieving oral liquid and method for preparing same |
| 12/27/2006 | CN1883542A Medicament with borneol and borax for treating rhinitis |
| 12/27/2006 | CN1883530A Laggera extracts with anti-virus, anti-inflammation and/or antibiotic functions and use thereof |
| 12/27/2006 | CN1883523A A compound lyophilized powder injection and preparation method thereof |
| 12/27/2006 | CN1883508A Anti-dust nasal cleanser |
| 12/27/2006 | CN1883507A An effervescence tablet of cold-treating preparation and preparation method thereof |
| 12/27/2006 | CN1883506A A low-sugar granule for treating infants cold and preparation method thereof |
| 12/27/2006 | CN1883480A A pharmaceutical composition containing rupatatine |
| 12/27/2006 | CN1883479A 一种定量滴剂 A quantitative drops |
| 12/27/2006 | CN1883472A Orally disintegrating tablet of ginkgolide and preparation method thereof |
| 12/27/2006 | CN1883442A A tooth decay-resistant spray and method for preparing same |
| 12/27/2006 | CN1292001C Nucleus factor-kB p50 subunit antagonist peptide, preparation and application thereof |
| 12/27/2006 | CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 12/27/2006 | CN1291986C Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions |
| 12/27/2006 | CN1291984C 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 12/27/2006 | CN1291740C Spray for treating rhinitis |
| 12/27/2006 | CN1291734C Quality control method of Chinese medicinal soft capsule |
| 12/27/2006 | CN1291731C Chinese medicine for treating pulmonary fibrosis due to chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis |
| 12/27/2006 | CN1291730C Application of goldenrod in preparation of medicine for preventing and treating SARS virus |
| 12/27/2006 | CN1291715C Pharmaceutical compositions containing epinastine and pseudoephedrine |
| 12/27/2006 | CN1291710C Dripping pills preparation and its preparing process |
| 12/26/2006 | US7153963 Phenylalanine derivatives |
| 12/26/2006 | US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 12/26/2006 | US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 12/26/2006 | US7153873 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 12/26/2006 | US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 12/26/2006 | US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer |
| 12/26/2006 | US7153852 Skin disorders; antiinflammatory agents; brain disorders; chronic obstructive pulmonary disease; antiarthritic agents; inflammatory bowel disorders |
| 12/26/2006 | US7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof |
| 12/21/2006 | WO2006135280A1 N-acylic aminoacid derivatives. method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents |
| 12/21/2006 | WO2006135254A1 Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion |
| 12/21/2006 | WO2006135109A1 Method for treatment of proliferative disease utilizing inhibition of formation of synoviolin homooligomer |
| 12/21/2006 | WO2006135080A1 Thienopyrimidine derivative |
| 12/21/2006 | WO2006134963A1 Agent for fibrous disease comprising oxaluric acid derivtive |
| 12/21/2006 | WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/21/2006 | WO2006134877A1 Injection |
| 12/21/2006 | WO2006134022A1 Mrp iv inhibitors for the treatment of respiratory diseases |
| 12/21/2006 | WO2006134021A2 Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof |
| 12/21/2006 | WO2006078899A3 Mucin hypersecretion inhibitors based on the structure of mans and methods of use |
| 12/21/2006 | WO2006056888A3 Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
| 12/21/2006 | US20060287389 Phenethanolamine derivatives for treatment of respiratory diseases |
| 12/21/2006 | US20060287380 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 12/21/2006 | US20060287369 Diarylmethyl and related compounds |
| 12/21/2006 | US20060287362 Organic compounds |
| 12/21/2006 | US20060287355 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 12/21/2006 | US20060287354 Azaindole compounds as kinase inhibitors |
| 12/21/2006 | US20060287340 e.g. 5-(4-fluorophenyl)-N-[2-(1-methyl-2-oxo-1,7-diazaspiro[4,4]nonan-7-yl)-6-quinolinyl]-2-pyrimidinecarboxamide; melanin concentrating hormone receptor antagonist; central nervous system disorders, cardiovascular disorders and metabolic disorders |
| 12/21/2006 | US20060287338 Metalloproteinase inhibitor compounds |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/21/2006 | US20060287286 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 12/21/2006 | US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis |
| 12/21/2006 | US20060286040 Medicament compositions comprising a heterocyclic compound and an anticholinergic |
| 12/21/2006 | CA2612324A1 N-acyl derivatives of amino acids, a process for preparation thereof, a pharmaceutical composition and use thereof as antiallergic, anti-inflammatory and hypolipidemic agents |
| 12/21/2006 | CA2611917A1 Injection |
| 12/21/2006 | CA2611907A1 Mrp iv inhibitors for the treatment of respiratory diseases |
| 12/21/2006 | CA2611386A1 Use of pde1c and inhibitors thereof |
| 12/21/2006 | CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/21/2006 | CA2597317A1 Uses of recombinant super-compound interferons |
| 12/20/2006 | EP1734121A2 Genetically engineered human-derived Kunitz domains that inhibit human neutrophil elastase |
| 12/20/2006 | EP1733728A2 Use of 2-alkoxyphenyl substituted imidazotriazinones as inhibitors of phosphodiesterase |
| 12/20/2006 | EP1733726A1 Pharmaceutically active isoindoline derivatives |
| 12/20/2006 | EP1733721A2 Use of astaxanthin or esters thereof as a phosphodiesterase inhibitor |
| 12/20/2006 | EP1733237A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferative activated receptor alpha (ppara) |
| 12/20/2006 | EP1732903A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd |
| 12/20/2006 | EP1732590A2 New pharmaceutical composition based on fluorenecarboxyclic acid esters and soluble tnf receptor fusion proteins |
| 12/20/2006 | EP1732561A1 Combination of cb2 modulators and pde4 inhibitors for use in medicine |
| 12/20/2006 | EP1732553A1 Compounds for treating proliferative processes |
| 12/20/2006 | EP1732531A2 Amines and amides for the treatment of diseases |
| 12/20/2006 | EP1732526A2 Salmeterol inhalation formulations |
| 12/20/2006 | EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 12/20/2006 | EP1539164B1 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors |
| 12/20/2006 | EP1506200B1 Diazabicyclic biaryl derivatives |
| 12/20/2006 | EP1401809B1 Tryptase inhibitors |
| 12/20/2006 | EP1276472B1 Formulations for use in inhaler devices |
| 12/20/2006 | EP1131294B1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 12/20/2006 | CN1882582A Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same |
| 12/20/2006 | CN1882556A Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 12/20/2006 | CN1882348A Carbohydrate composition and its use for the preparation of a medicament for treating or preventing pulmonary inflammation or acute respiration distress syndrome |
| 12/20/2006 | CN1882322A Patch |
| 12/20/2006 | CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 12/20/2006 | CN1879871A Soup formulation for treating phlegm and qi stasis type cirrhosis, and its preparation method |
| 12/20/2006 | CN1879859A Medicine for treating cold |
| 12/20/2006 | CN1879848A A medicine for treating pharyngitis |
| 12/20/2006 | CN1879844A A medicine for treating tracheitis |
| 12/20/2006 | CN1879803A A cough-stopping granule and method for preparing same |
| 12/20/2006 | CN1879800A A medicinal liquor for treating lung-heat yin-deficiency type laryngeal obstruction and method for preparing same |
| 12/20/2006 | CN1879797A A Chinese proprietary medicine for mainly treating bronchitis and asthma and method for preparing same |
| 12/20/2006 | CN1879791A A nasal drop for treating rhinitis and method for preparing same |
| 12/20/2006 | CN1879785A Dragonis sanguis preparation and application thereof |
| 12/20/2006 | CN1879780A A medicinal liquor for treating liver-qi stagnant type laryngeal obstruction and method for preparing same |
| 12/20/2006 | CN1879773A A medicinal liquor for treating phlegm fire interlocked laryngeal obstruction and method for preparing same |
| 12/20/2006 | CN1879759A Chinese medicine for treating acute pharyngitis |
| 12/20/2006 | CN1879737A Medicament for treating poultry infectious laryngotracheitis |
| 12/20/2006 | CN1879707A 'Shuang Huang Lian' pills and preparation method thereof |
| 12/20/2006 | CN1879706A 'Shuang Huang Lian' dispersible tablet and preparation method thereof |